Cargando…

Medium term results following heart transplantation for end stage heart failure: A single center experience of 257 patients()

OBJECTIVE: End stage heart failure is a lethal disease with a dismal 5 year survival. Heart transplantation has proven to be a highly effective modality of treatment in appropriately selected group of such patients. This is a retrospective analysis of medium term outcomes of heart transplantation in...

Descripción completa

Detalles Bibliográficos
Autores principales: Balakrishnan, K.R., Sureshrao, K.G., Ravikumar, R., Muralikrishna, T., Ganapathy Subramaniam, K., Mohan, R., Ajay, A., Ramasubramanian, K., Jagdish, D., Veena, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772589/
https://www.ncbi.nlm.nih.gov/pubmed/33357640
http://dx.doi.org/10.1016/j.ihj.2020.09.010
_version_ 1783629905051779072
author Balakrishnan, K.R.
Sureshrao, K.G.
Ravikumar, R.
Muralikrishna, T.
Ganapathy Subramaniam, K.
Mohan, R.
Ajay, A.
Ramasubramanian, K.
Jagdish, D.
Veena, R.
author_facet Balakrishnan, K.R.
Sureshrao, K.G.
Ravikumar, R.
Muralikrishna, T.
Ganapathy Subramaniam, K.
Mohan, R.
Ajay, A.
Ramasubramanian, K.
Jagdish, D.
Veena, R.
author_sort Balakrishnan, K.R.
collection PubMed
description OBJECTIVE: End stage heart failure is a lethal disease with a dismal 5 year survival. Heart transplantation has proven to be a highly effective modality of treatment in appropriately selected group of such patients. This is a retrospective analysis of medium term outcomes of heart transplantation in the setting of a private health facility in India. The objective of this study was two fold. 1;. 1.. To document the short term and medium term survival of patients undergoing a heart transplant procedure; 2.. To identify the risk factors for unfavorable outcomes with subgroup analysis. METHODS: The outcome of 257 heart transplants done at a single centre from October 2012 to October 2019 was analyzed. Patients with combined Heart and lung transplants and those whose complete medical records were unavailable were excluded from the study. Survival was tracked at 60 days, 90 days, one year and beyond for a maximum of 7 years. Preoperative patient risk profiles were characterized on the basis of INTERMACS category. RESULTS: There were 176 male and 81 female patients. The age range was from 8 months to 78 years with a mean of 32.9 years. Survival at 2 months was 87%, at 90 days was 83%, at one year was 81%, 2 years was 75%, at 3 years was 72% and at 5 years and beyond was 62% for the whole series. Strong predictors of 90 day mortality included INTERMACS category (odd's ratio 0.289, p = 0.000) and creatinine more than 1.5 mg/dl (odd's ratio 2.48, p = 0.056). Recipient pulmonary vascular resistance and donor organ ischemic times were not found to be statistically significant factors affecting outcome. Medium term survival was influenced by INTERMACS category (Hazard ratio > 3 for INTERMACS category 1 compared to INTERMACS 4 or 5, p < 0.0001) and creatinine > 1.5 mg/dl (Hazard ratio 2.15, p = 0.003). This effect of creatinine was related to the age of the recipient. Hazard ratio 1.4, p = 0.524 if age <30 and Hazard ratio 4.78, p = 0.006, if age was >50. CONCLUSION: Satisfactory medium term outcome is possible after heart transplantation even in resource constrained environment of a developing country.
format Online
Article
Text
id pubmed-7772589
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-77725892020-12-30 Medium term results following heart transplantation for end stage heart failure: A single center experience of 257 patients() Balakrishnan, K.R. Sureshrao, K.G. Ravikumar, R. Muralikrishna, T. Ganapathy Subramaniam, K. Mohan, R. Ajay, A. Ramasubramanian, K. Jagdish, D. Veena, R. Indian Heart J Original Article OBJECTIVE: End stage heart failure is a lethal disease with a dismal 5 year survival. Heart transplantation has proven to be a highly effective modality of treatment in appropriately selected group of such patients. This is a retrospective analysis of medium term outcomes of heart transplantation in the setting of a private health facility in India. The objective of this study was two fold. 1;. 1.. To document the short term and medium term survival of patients undergoing a heart transplant procedure; 2.. To identify the risk factors for unfavorable outcomes with subgroup analysis. METHODS: The outcome of 257 heart transplants done at a single centre from October 2012 to October 2019 was analyzed. Patients with combined Heart and lung transplants and those whose complete medical records were unavailable were excluded from the study. Survival was tracked at 60 days, 90 days, one year and beyond for a maximum of 7 years. Preoperative patient risk profiles were characterized on the basis of INTERMACS category. RESULTS: There were 176 male and 81 female patients. The age range was from 8 months to 78 years with a mean of 32.9 years. Survival at 2 months was 87%, at 90 days was 83%, at one year was 81%, 2 years was 75%, at 3 years was 72% and at 5 years and beyond was 62% for the whole series. Strong predictors of 90 day mortality included INTERMACS category (odd's ratio 0.289, p = 0.000) and creatinine more than 1.5 mg/dl (odd's ratio 2.48, p = 0.056). Recipient pulmonary vascular resistance and donor organ ischemic times were not found to be statistically significant factors affecting outcome. Medium term survival was influenced by INTERMACS category (Hazard ratio > 3 for INTERMACS category 1 compared to INTERMACS 4 or 5, p < 0.0001) and creatinine > 1.5 mg/dl (Hazard ratio 2.15, p = 0.003). This effect of creatinine was related to the age of the recipient. Hazard ratio 1.4, p = 0.524 if age <30 and Hazard ratio 4.78, p = 0.006, if age was >50. CONCLUSION: Satisfactory medium term outcome is possible after heart transplantation even in resource constrained environment of a developing country. Elsevier 2020 2020-09-19 /pmc/articles/PMC7772589/ /pubmed/33357640 http://dx.doi.org/10.1016/j.ihj.2020.09.010 Text en © 2020 Cardiological Society of India. Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Balakrishnan, K.R.
Sureshrao, K.G.
Ravikumar, R.
Muralikrishna, T.
Ganapathy Subramaniam, K.
Mohan, R.
Ajay, A.
Ramasubramanian, K.
Jagdish, D.
Veena, R.
Medium term results following heart transplantation for end stage heart failure: A single center experience of 257 patients()
title Medium term results following heart transplantation for end stage heart failure: A single center experience of 257 patients()
title_full Medium term results following heart transplantation for end stage heart failure: A single center experience of 257 patients()
title_fullStr Medium term results following heart transplantation for end stage heart failure: A single center experience of 257 patients()
title_full_unstemmed Medium term results following heart transplantation for end stage heart failure: A single center experience of 257 patients()
title_short Medium term results following heart transplantation for end stage heart failure: A single center experience of 257 patients()
title_sort medium term results following heart transplantation for end stage heart failure: a single center experience of 257 patients()
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772589/
https://www.ncbi.nlm.nih.gov/pubmed/33357640
http://dx.doi.org/10.1016/j.ihj.2020.09.010
work_keys_str_mv AT balakrishnankr mediumtermresultsfollowinghearttransplantationforendstageheartfailureasinglecenterexperienceof257patients
AT sureshraokg mediumtermresultsfollowinghearttransplantationforendstageheartfailureasinglecenterexperienceof257patients
AT ravikumarr mediumtermresultsfollowinghearttransplantationforendstageheartfailureasinglecenterexperienceof257patients
AT muralikrishnat mediumtermresultsfollowinghearttransplantationforendstageheartfailureasinglecenterexperienceof257patients
AT ganapathysubramaniamk mediumtermresultsfollowinghearttransplantationforendstageheartfailureasinglecenterexperienceof257patients
AT mohanr mediumtermresultsfollowinghearttransplantationforendstageheartfailureasinglecenterexperienceof257patients
AT ajaya mediumtermresultsfollowinghearttransplantationforendstageheartfailureasinglecenterexperienceof257patients
AT ramasubramaniank mediumtermresultsfollowinghearttransplantationforendstageheartfailureasinglecenterexperienceof257patients
AT jagdishd mediumtermresultsfollowinghearttransplantationforendstageheartfailureasinglecenterexperienceof257patients
AT veenar mediumtermresultsfollowinghearttransplantationforendstageheartfailureasinglecenterexperienceof257patients